Filing Details
- Accession Number:
- 0001179110-12-009356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-31 10:59:00
- Reporting Period:
- 2012-05-29
- Filing Date:
- 2012-05-31
- Accepted Time:
- 2012-05-31 10:59:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-05-29 | 2,110 | $13.79 | 331,719 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 226,326 | Indirect | Craig Wheeler revocable trust |
Footnotes
- This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on November 25, 2009.
- This transaction was executed in multiple trades at prices ranging from $13.78 to $13.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.